Germany’s Merck KGaA agreed to acquire U.S. biopharmaceutical company SpringWorks Therapeutics for around $3.9 billion, in a bid to expand its oncology and rare disease business. The German life ...

Stokes also sees more at play than just a disagreement over trade deficits. Trump’s threats “are rooted in frustration with ...

eBay and Facebook are teaming up in a surprise move that will affect how people buy and sell on both platforms ... The feature is being tested in the US, Germany, and France.

German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks Therapeutics for around $3.9 billion, expanding its portfolio of rare disease and cancer ...

“Starting point for the negotiations is a possible offer price of €62 per Covestro share that Adnoc has indicated to Covestro, which is subject, among other things, to the results of the ...

(Reuters) - Germany's Merck KGaA said on Thursday it is ... In 2015, Merck agreed to buy U.S. lab equipment supplier Sigma-Aldrich for $17 billion. Reuters reported in February that the companies ...